News

World Contraception Day versus Spread scientific evidence!

26th September is #WorldContraceptionDay. The aim of the day is not only to create awareness but also to spread facts and scientific evidence #WCD2020 Watch our webinar recording on Breast cancer risk associated with hormonal contraception and menopause hormone treatment https://escrh.eu/education/webinars Our ESC training improvement...

26 September, 2020

Journal highlight, Volume 25, Issue 5

Johannes Bitzer (Editor-in-Chief) chose the following paper as highlight from the latest issue of the European Journal of Contraception and Reproductive Health Care: Qualitative findings about stigma as a barrier to contraception use: the case of Emergency Hormonal Contraception in Britain and implications for future...

25 September, 2020

IUD – IUS sessions are now UPDATED

Intrauterine devices (IUDs) Overview, Cu-IUDs, LNG 20 IUS PDF / PDF With notes Levonorgestrel-releasing intrauterine system (LNG-IUS) PDF / PDF With notes Intrauterine devices in special situations PDF / PDF With notes All sessions Sit down with your colleagues or residents and study the slides!...

23 September, 2020

Registration is open: ESC Webinar, 16 September 2020, 4PM CET

ESC Webinar: Breast cancer risk associated with hormonal contraception and menopause hormone treatment 16 September 2020 4 PM Central European Time Duration: 1 hour 30 minutes Hormonal contraception and breast cancer Gabriele Merki-Feld, MD PhD, Switzerland Breast cancer and menopause hormone therapy Anne Gompel, MD...

01 September, 2020

Save the date: ESC Webinar, 16 September 2020, 4PM CET

ESC Webinar: Breast cancer risk associated with hormonal contraception and menopause hormone treatment 16 September 2020 4 PM Central EuropeanTime Duration: 1 hour 30 minutes Hormonal contraception and breast cancer Gabriele Merki-Feld, MD PhD, Switzerland Breast cancer and menopause hormone therapy Anne Gompel, MD PhD,...

21 August, 2020

POC Sessions 1-4 are now UPDATED

Progestin-only contraceptives (POCs) have become a popular alternative to combined hormonal contraceptives (CHC) as they are not associated with an increase in the risk of venous thrombosis or arterial events such as myocardial infarction or stroke. Oral POCs are very low dose and have minimal...

17 August, 2020